期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
肠道准备后2 h即行无痛肠镜检查的安全性及有效性研究 被引量:3
1
作者 黄建朋 袁晓珊 +4 位作者 宗华 陶红光 朱胜彬 杨骏波 李莹 《中国内镜杂志》 2022年第2期12-15,共4页
目的探讨肠道准备后2 h即行无痛肠镜检查的安全性及有效性。方法将120名志愿者随机分为观察组和对照组,观察组行快速肠道准备,对照组行常规肠道准备。比较两组患者肠道准备过程中恶心、呕吐发生率、检查完成率、检查时长、检查过程中误... 目的探讨肠道准备后2 h即行无痛肠镜检查的安全性及有效性。方法将120名志愿者随机分为观察组和对照组,观察组行快速肠道准备,对照组行常规肠道准备。比较两组患者肠道准备过程中恶心、呕吐发生率、检查完成率、检查时长、检查过程中误吸发生率、息肉检出率和Boston肠道准备量表(BBPS)评分。结果两组患者均全部完成检查,检查过程中无呕吐和误吸等不良事件发生。观察组和对照组平均检查时长分别为(15.50±4.41)和(17.07±4.43)min,息肉检出率分别为28.3%(17/60)和31.7%(19/60),两组比较,差异无统计学意义(P>0.05);观察组和对照组肠道准备过程中恶心、呕吐发生率分别为36.7%(22/60)和63.3%(38/60),BBPS评分分别为(8.88±0.32)和(8.63±0.55)分,两组比较,差异有统计学意义(P<0.05)。结论对于无消化道症状的健康体检者,在快速肠道准备情况下,肠道准备后2 h即行无痛肠镜检查,不会增加误吸发生率,也不影响肠道准备质量,且可明显降低肠道准备过程中恶心和呕吐等不良反应的发生率。 展开更多
关键词 快速肠道准备 禁饮时间 肠道准备质量 不良反应 安全
下载PDF
胃镜检查禁饮时间缩短至2小时的安全性研究 被引量:3
2
作者 黄建朋 王春飞 +3 位作者 田琼 石威文 刘秋月 陈露红 《中国内镜杂志》 2020年第9期25-28,共4页
目的探讨将胃镜检查禁饮时间缩短至2 h的安全性。方法将180名志愿者随机分为观察组A(饮水500.00 mL)、观察组B(饮水大于500.00 mL)和对照组C(禁饮时间大于8 h),观察组饮水后每15.00 min经腹部彩超行胃内液体容积测定至胃排空,然后行胃... 目的探讨将胃镜检查禁饮时间缩短至2 h的安全性。方法将180名志愿者随机分为观察组A(饮水500.00 mL)、观察组B(饮水大于500.00 mL)和对照组C(禁饮时间大于8 h),观察组饮水后每15.00 min经腹部彩超行胃内液体容积测定至胃排空,然后行胃镜检查,用胃镜吸尽残留液体量并用量杯计量。比较3组2 h后胃内残留液体量、检查完成率和误吸发生率。结果观察组A排空时间为15.00~75.00 min,平均排空时间39.81 min,胃镜测得胃内残留液体量5.00~50.00 mL,平均20.38 mL;观察组B排空时间为15.00~75.00 min,平均排空时间40.38 min,胃镜测得胃内残留液体量10.00~60.00 mL,平均24.81 mL;对照组C胃镜测得胃内残留液体量0.00~60.00 mL,平均25.95 mL,3组比较,差异无统计学意义(P>0.05)。所有志愿者均全部完成检查,均未发生误吸。结论无排空障碍受试者饮水少于1000.00 mL,在75 min内均可排空,胃镜检查禁饮时间缩短至2 h安全可行。 展开更多
关键词 胃镜检查 禁饮时间 饮水量 误吸 可行性
下载PDF
Potential role of long noncoding RNA RP5-881L22.5 as a novel biomarker and therapeutic target of colorectal cancer
3
作者 Hua Zong Jian-Qiang Zou +1 位作者 jian-peng huang Shi-Ting huang 《World Journal of Gastrointestinal Oncology》 SCIE 2022年第11期2108-2121,共14页
BACKGROUND The incidence of colorectal cancer in humans is high,and it is in the top five for cancer-related morbidity and mortality.It is one of the main threats to human health.The function of long noncoding RNAs in... BACKGROUND The incidence of colorectal cancer in humans is high,and it is in the top five for cancer-related morbidity and mortality.It is one of the main threats to human health.The function of long noncoding RNAs in tumor occurrence and development has gradually gained attention in recent years.In increasing numbers of studies,researchers have demonstrated that it plays an important role in the pathogenesis of colorectal cancer.AIM To find out if long noncoding RNA RP5-881L22.5 played a role in the pathogenesis of colorectal cancer in relation to the tumor microenvironment.METHODS We analyzed the transcriptome data and clinical data in The Cancer Genome Atlas-colon adenocarcinoma.The CIRBERSORT algorithm was applied to evaluate these tumor-infiltrating immune cells in The Cancer Genome Atlas-colon adenocarcinoma cancer tissue samples.Using the“estimate”package in R,we assessed the tumor immune microenvironment.The expression level of RP5-881L22.5 in tumor tissue and adjacent normal tissue samples from 4 pairs of colorectal cancer patients was determined by quantitative reverse transcription PCR.Colorectal cancer cells were tested for invasiveness using a transwell invasion assay after RP5-881L22.5 expression was knocked down.RESULTS The expression of lncRNA RP5-881L22.5 was related to the clinical characteristics of the tumors,and it was negatively related to the infiltration level of immune cells in the tumor microenvironment and the expression of T cell inhibitory receptors.A major function of its coexpressed mRNA was to regulate tumor immunity,such as the immune response.When quantitative reverse transcription PCR was performed on tumor tissues from 4 pairs of colorectal cancer patients,the results showed that RP5-881L22.5 was highly expressed.Subsequently,knocking down the expression of RP5-881L22.5,the invasiveness of colorectal cancer cell lines was reduced,and the apoptosis rate was increased.CONCLUSION RP5-881L22.5 plays a crucial role in the microenvironment of tumors as well as in the pathogenesis of colorectal cancer.The relationship between RP5-881L22.5 and the tumor immune microenvironment deserves further study. 展开更多
关键词 Colorectal cancer Long noncoding RNA RP5-881L22.5 Tumor immune microenvironment BIOMARKER Therapeutic target
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部